The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Central role of RAGE-dependent neointimal expansion in arterial restenosis
Open accessAbstract
Cellular proliferation, migration, and expression of extracellular matrix proteins and MMPs contribute to neointimal formation upon vascular injury. Wild-type mice undergoing arterial endothelial denudation displayed striking upregulation of receptor for advanced glycation end products (RAGE) in the injured vessel, particularly in activated smooth muscle cells of the expanding neointima. In parallel, two of RAGE's signal transducing ligands, advanced glycation end products (AGEs) and S100/calgranulins, demonstrated increased deposition/expression in the injured vessel wall. Blockade of RAGE, employing soluble truncated receptor or antibodies, or in homozygous RAGE null mice, resulted in significantly decreased neointimal expansion after arterial injury and decreased smooth muscle cell proliferation, migration, and expression of extracellular matrix proteins. A critical role for smooth muscle cell RAGE signaling was demonstrated in mice bearing a transgene encoding a RAGE cytosolic tail-deletion mutant, specifically in smooth muscle cells, driven by the SM22alpha promoter. Upon arterial injury, neointimal expansion was strikingly suppressed compared with that observed in wild-type littermates. Taken together, these data highlight key roles for RAGE in modulating smooth muscle cell properties after injury and suggest that RAGE is a logical target for suppression of untoward neointimal expansion consequent to arterial injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Morice, M.-C., Serruys, P. W., Sousa, J. E., Fajadet, J., Ban Hayashi, E., Perin, M., Colombo, A., Schuler, G., Barragan, P., Guagliumi, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012843 · Cited by 4,033
Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein E
Zhang, S. H., Reddick, R. L., Piedrahita, J. A., & Maeda, N. (1992) · Science · doi:10.1126/science.1411543 · Cited by 2,237
RAGE Mediates a Novel Proinflammatory Axis
Hofmann, M. A., Drury, S., Fu, C., Qu, W., Taguchi, A., Lu, Y., Avila, C., Kambham, N., Bierhaus, A., Nawroth, P., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80801-6 · Cited by 1,864
Self-citationApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.
Nakashima, Y., Plump, A. S., Raines, E. W., Breslow, J. L., & Ross, R. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.1.133 · Cited by 1,693
Johnson, D. A., Gautsch, J. W., Sportsman, J. R., & Elder, J. H. (1984) · Gene Analysis Techniques · doi:10.1016/0735-0651(84)90049-9 · Cited by 1,672
Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases
Taguchi, A., Blood, D. C., del Toro, G., Canet, A., Lee, D. C., Qu, W., Tanji, N., Lu, Y., Lalla, E., Fu, C., et al. (2000) · Nature · doi:10.1038/35012626 · Cited by 1,217
Self-citationPark, L., Raman, K. G., Lee, K. J., Lu, Y., Ferran, L. J., Chow, W. S., Stern, D., & Schmidt, A. M. (1998) · Nature Medicine · doi:10.1038/2012 · Cited by 1,104
Self-citationThe S100 family of EF-hand calcium-binding proteins: functions and pathology
SCHAFER, B. (1996) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(96)10020-7 · Cited by 999
Liu, M. W., Roubin, G. S., & King, S. B. (1989) · Circulation · doi:10.1161/01.cir.79.6.1374 · Cited by 927
Research works printed but not linked: 9
- 10.1053/euhj.1999.1545 · doi:10.1053/euhj.1999.1545
- 10.1161/01.CIR.0000038984.30279.89 · doi:10.1161/01.cir.0000038984.30279.89
- 10.1097/00019501-200205000-00008 · doi:10.1097/00019501-200205000-00008
- Tarvo, 1980, Blood Vessels., 17, 110
- Roque, 2001, Lab. Invest., 81, 895, 10.1038/labinvest.3780298 · doi:10.1038/labinvest.3780298
- 10.1067/mva.2000.109763 · doi:10.1067/mva.2000.109763
- Schafer, 1996, TIBS., 21, 134
- Barron, 1997, Circulation., 96, 3587, 10.1161/01.CIR.96.10.3587 · doi:10.1161/01.cir.96.10.3587
- Friedman, 1994, Circulation., 90, 1567
Cited by
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
Lotze, M. T., & Tracey, K. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1594 · Cited by 2,487
Mechanisms, Pathophysiology, and Therapy of Arterial Stiffness
Zieman, S. J., Melenovsky, V., & Kass, D. A. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000160548.78317.29 · Cited by 1,854
HMGB1 and RAGE in Inflammation and Cancer
Sims, G. P., Rowe, D. C., Rietdijk, S. T., Herbst, R., & Coyle, A. J. (2010) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132603 · Cited by 1,436
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
Deane, R., Du Yan, S., Submamaryan, R. K., LaRue, B., Jovanovic, S., Hogg, E., Welch, D., Manness, L., Lin, C., Yu, J., et al. (2003) · Nature Medicine · doi:10.1038/nm890 · Cited by 1,611
Self-citationUnderstanding RAGE, the receptor for advanced glycation end products
Bierhaus, A., Humpert, P. M., Morcos, M., Wendt, T., Chavakis, T., Arnold, B., Stern, D. M., & Nawroth, P. P. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0688-7 · Cited by 1,297
“Neointimal expansion in RAGE mice was significantly suppressed compared with that observed in wildtype littermates using a femoral artery denudation protocol to induce arterial injury [71].”
MethodSelf-citationBASTA, G. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.05.001 · Cited by 999
Ramasamy, R., Vannucci, S. J., Yan, S. S. D., Herold, K., Yan, S. F., & Schmidt, A. M. (2005) · Glycobiology · doi:10.1093/glycob/cwi053 · Cited by 834
Self-citationDiabetes and advanced glycation endproducts
Vlassara, H., & Palace, M. R. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.00932.x · Cited by 697
The Pattern Recognition Receptor (RAGE) Is a Counterreceptor for Leukocyte Integrins
Chavakis, T., Bierhaus, A., Al-Fakhri, N., Schneider, D., Witte, S., Linn, T., Nagashima, M., Morser, J., Arnold, B., Preissner, K. T., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030800 · Cited by 582
Self-citationCellular signalling of the receptor for advanced glycation end products (RAGE)
Xie, J., Méndez, J. D., Méndez-Valenzuela, V., & Aguilar-Hernández, M. M. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.06.013 · Cited by 513
Yan, S. F., Ramasamy, R., Naka, Y., & Schmidt, A. M. (2003) · Circulation Research · doi:10.1161/01.res.0000103862.26506.3d · Cited by 513
Self-citationTargeting RAGE Signaling in Inflammatory Disease
Hudson, B. I., & Lippman, M. E. (2018) · Annual Review of Medicine · doi:10.1146/annurev-med-041316-085215 · Cited by 502
Mechanism of Development of Atherosclerosis and Cardiovascular Disease in Diabetes Mellitus
Katakami, N. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv17014 · Cited by 472
RAGE regulation and signaling in inflammation and beyond
Kierdorf, K., & Fritz, G. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.1012519 · Cited by 428
Hyperglycemia and Glycation in Diabetic Complications
Negre-Salvayre, A., Salvayre, R., Augé, N., Pamplona, R., & Portero-Otín, M. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2484 · Cited by 421
Soro-Paavonen, A., Watson, A. M. D., Li, J., Paavonen, K., Koitka, A., Calkin, A. C., Barit, D., Coughlan, M. T., Drew, B. G., Lancaster, G. I., et al. (2008) · Diabetes · doi:10.2337/db07-1808 · Cited by 407
Self-citationAdvanced glycation end products and the kidney
Bohlender, J. M., Franke, S., Stein, G., & Wolf, G. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00398.2004 · Cited by 387
Falcone, C., Emanuele, E., D’Angelo, A., Buzzi, M. P., Belvito, C., Cuccia, M., & Geroldi, D. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000160342.20342.00 · Cited by 377
Changes in aqueous humor dynamics with age and glaucoma
Gabelt, B. T., & Kaufman, P. L. (2005) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2004.10.003 · Cited by 377
Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE–/– mice
Harja, E., Bu, D.-X., Hudson, B. I., Chang, J. S., Shen, X., Hallam, K., Kalea, A. Z., Lu, Y., Rosario, R. H., Oruganti, S., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32703 · Cited by 364
Self-citationHudson, B. I., Kalea, A. Z., del Mar Arriero, M., Harja, E., Boulanger, E., D'Agati, V., & Schmidt, A. M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801465200 · Cited by 358
Self-citationBasta, G. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.07.025 · Cited by 357
Inflammation-associated S100 proteins: new mechanisms that regulate function
Goyette, J., & Geczy, C. L. (2011) · Amino Acids · doi:10.1007/s00726-010-0528-0 · Cited by 345
Diabetes and Advanced Glycoxidation End Products
Huebschmann, A. G., Regensteiner, J. G., Vlassara, H., & Reusch, J. E. B. (2006) · Diabetes Care · doi:10.2337/dc05-2096 · Cited by 330
Bierhaus, A., & Nawroth, P. P. (2009) · Diabetologia · doi:10.1007/s00125-009-1458-9 · Cited by 314
Self-citationKume, S., Kato, S., Yamagishi, S.-I., Inagaki, Y., Ueda, S., Arima, N., Okawa, T., Kojiro, M., & Nagata, K. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050514 · Cited by 303
Yamagishi, S.-I. (2011) · Experimental Gerontology · doi:10.1016/j.exger.2010.11.007 · Cited by 302
Yamagishi, S.-I., Maeda, S., Matsui, T., Ueda, S., Fukami, K., & Okuda, S. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.03.014 · Cited by 294
RAGE-mediated signaling contributes to intraneuronal transport of amyloid-β and neuronal dysfunction
Takuma, K., Fang, F., Zhang, W., Yan, S., Fukuzaki, E., Du, H., Sosunov, A., McKhann, G., Funatsu, Y., Nakamichi, N., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905686106 · Cited by 290
“RAGE knockout (RAGE / ) mice have been described previously (35, 50).”
MethodSelf-citationRAGE: therapeutic target and biomarker of the inflammatory response—the evidence mounts
Ramasamy, R., Yan, S. F., & Schmidt, A. M. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0409230 · Cited by 283
“Other signaling pathways linked to RAGE include Jak/STAT and src kinase, particularly in smooth muscle cells [36, 37], PI3K [32, 38], TGF- /Smad [39], and members of the Rho GTPase signaling pathway (particularly cdc42 and rac-1) [40–42].”
BackgroundSelf-citationVincent, A. M., Perrone, L., Sullivan, K. A., Backus, C., Sastry, A. M., Lastoskie, C., & Feldman, E. L. (2007) · Endocrinology · doi:10.1210/en.2006-0073 · Cited by 258
Receptor for Advanced-Glycation End Products: Key Modulator of Myocardial Ischemic Injury
Bucciarelli, L. G., Kaneko, M., Ananthakrishnan, R., Harja, E., Lee, L. K., Hwang, Y. C., Lerner, S., Bakr, S., Li, Q., Lu, Y., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.575993 · Cited by 256
Self-citationFernando, D. H., Forbes, J. M., Angus, P. W., & Herath, C. B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205037 · Cited by 184
Nedić, O., Rattan, S. I. S., Grune, T., & Trougakos, I. P. (2013) · Free Radical Research · doi:10.3109/10715762.2013.806798 · Cited by 162
“Also, smooth muscle cell proliferation, migration and neointimal expansion upon arterial injury were strikingly suppressed in homozygous RAGE null mice compared with those observed in wildtype littermates [84].”
BackgroundAleshin, A., Ananthakrishnan, R., Li, Q., Rosario, R., Lu, Y., Qu, W., Song, F., Bakr, S., Szabolcs, M., D'Agati, V., et al. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01210.2007 · Cited by 143
Self-citationTsoporis, J. N., Izhar, S., Leong-Poi, H., Desjardins, J.-F., Huttunen, H. J., & Parker, T. G. (2010) · Circulation Research · doi:10.1161/circresaha.109.195834 · Cited by 118
Origlia, N., Bonadonna, C., Rosellini, A., Leznik, E., Arancio, O., Yan, S. S., & Domenici, L. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.2127-10.2010 · Cited by 111
“Homozygous RAGE-null mice were generated and characterized as described previously (Sakaguchi et al., 2003; Wendt et al., 2003).”
MethodSelf-citationHofmann Bowman, M. A., Gawdzik, J., Bukhari, U., Husain, A. N., Toth, P. T., Kim, G., Earley, J., & McNally, E. M. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.217745 · Cited by 111
Fang, F., Yu, Q., Arancio, O., Chen, D., Gore, S. S., Yan, S. S., & Yan, S. F. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy017 · Cited by 103
Shang, L., Ananthakrishnan, R., Li, Q., Quadri, N., Abdillahi, M., Zhu, Z., Qu, W., Rosario, R., Touré, F., Yan, S. F., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010092 · Cited by 93
“AGEs interact with the receptor for AGEs (RAGE) which results in the propagation of stress signals and activation of MAPKs, NFkB, and several proapoptotic pathways [8,9].”
BackgroundSelf-citationStochastic non-enzymatic modification of long-lived macromolecules - A missing hallmark of aging
Fedintsev, A., & Moskalev, A. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101097 · Cited by 72
Arguing for the motion: yes, RAGE is a receptor for advanced glycation endproducts
Ramasamy, R., Yan, S. F., & Schmidt, A. M. (2007) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700008 · Cited by 58
Metadata
- Authors
- Sakaguchi, T., Yan, S. F., Yan, S. D., Belov, D., Rong, L. L., Sousa, M., Andrassy, M., Marso, S. P., Duda, S., Arnold, B., Liliensiek, B., Nawroth, P. P., Stern, D. M., Schmidt, A. M., & Naka, Y.
- Venue
- Journal of Clinical Investigation
- Published
- 2003-04-01
- Volume
- 111
- Issue
- 7
- Pages
- 959-972
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2144319892
- Cited by
- 367
- References
- 64
- FWCI
- 14.62
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.